Sangui Biotech International (Sangui Biotech International) Market Cap : $0.32 Mil (As of Apr. 28, 2024)

View and export this data going back to . Start your Free Trial

What is Sangui Biotech International Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sangui Biotech International's share price for the quarter that ended in Mar. 2023 was $0.0046. Sangui Biotech International's Shares Outstanding (EOP) for the quarter that ended in Mar. 2023 was 209.90 Mil. Therefore, Sangui Biotech International's market cap for the quarter that ended in Mar. 2023 was $0.97 Mil.

Sangui Biotech International's quarterly market cap declined from Sep. 2022 ($2.41 Mil) to Dec. 2022 ($0.93 Mil) but then increased from Dec. 2022 ($0.93 Mil) to Mar. 2023 ($0.97 Mil).

Sangui Biotech International's annual market cap increased from Jun. 2020 ($2.94 Mil) to Jun. 2021 ($4.57 Mil) but then declined from Jun. 2021 ($4.57 Mil) to Jun. 2022 ($2.10 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sangui Biotech International's Enterprise Value for Today is $1.14 Mil.

Sangui Biotech International Market Cap Historical Data

The historical data trend for Sangui Biotech International's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sangui Biotech International Market Cap Chart

Sangui Biotech International Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Market Cap

Get a 7-Day Free Trial

3.84

1.99

2.94

4.57

2.10

Sangui Biotech International Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Market Cap	Get a 7-Day Free Trial															3.93	2.10	2.41	0.93	0.97

Competitive Comparison of Sangui Biotech International's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Sangui Biotech International's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sangui Biotech International's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sangui Biotech International's Market Cap distribution charts can be found below:

* The bar in red indicates where Sangui Biotech International's Market Cap falls into.

Sangui Biotech International Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Sangui Biotech International's Market Cap for the fiscal year that ended in Jun. 2022 is calculated as

Market Cap (A: Jun. 2022 )	=	Share Price (A: Jun. 2022 )	*	Shares Outstanding (EOP) (A: Jun. 2022 )
	=	$0.01	*	209.902
	=	$2.10

Sangui Biotech International's Market Cap for the quarter that ended in Mar. 2023 is calculated as

Market Cap (Q: Mar. 2023 )	=	Share Price (Q: Mar. 2023 )	*	Shares Outstanding (EOP) (Q: Mar. 2023 )
	=	$0.0046	*	209.902
	=	$0.97

Sangui Biotech International (OTCPK:SGBI) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Sangui Biotech International Market Cap Related Terms

Thank you for viewing the detailed overview of Sangui Biotech International's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Sangui Biotech International (Sangui Biotech International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sangui Biotech International Inc (OTCPK:SGBI) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

SBH:Germany

Address

Bleichenbrucke 9, Hamburg, DEU, 20354

Website

http://www.sanguibiotech.com

Sangui Biotech International Inc develops pharmaceutical, medical and cosmetic products, through its subsidiary. The company develops oxygen carriers for providing oxygen transport in humans due to acute or chronic lack of oxygen and in the case of chronic wounds. It has also developed external applications of oxygen transporters in the form of sprays for healing chronic wounds and gels and emulsions for the regeneration of the skin. The products offered are artificial oxygen carriers; Chitoskin wound pads; and haemoglobin-based wound spray technology sold under the brand name Granulox. It derives revenue from licensing fees on sales of its wound spray product.

Executives

Hubertus Schmelz	director	NEUER WALL 54, HAMBURG 2M D-20354
Joachim Fleing	director	ALFRED HERRHAUSENSTR 44, WITTEN 2M 58455
Thomas Striepe	director	NEUER WALL 54, HAMBURG 2M D-20354
Wolfgang Barnikol	director	ALFRED HERRHAUSEN STR 44, WITTEN 2M 58455
Lutz Joachim	director	ALFRED-HERRHAUSEN-ST. 44, WITTEN 2M 58455
Christoph Ludz	director	SANDERSKOPPEL 17, HAMBURG 2M 22391

Sangui Biotech International (Sangui Biotech International) Headlines

No Headlines